Patent · US Active

Construct for epigenetic modification and its use in the silencing of genes

US11072782B2 · kind B2 · utility

7Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2018
Grant dateJul 27, 2021
Priority date
Expiry dateMay 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Herein described is a construct for epigenomic modification of genes composed of: (a) a Krüppel-associated box zinc finger protein or homologous, (b) a DNA region capable of binding to the target gene or homologous, (c) a human DNA methyltransferase DNMT3A or homologous and (d) a murine DNA methyltransferase Dnmt3L or homologous, wherein components a), b), c) and d) are linked to each other either directly or via at least one linker. The construct is a designer epigenome modifier that can be used to silence genes coding for a protein in leukocytes that avoids the internalization of HI viruses in immune cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.